Refractory Differentiated Thyroid Gland Carcinoma

general

A differentiated thyroid gland carcinoma that is resistant to treatment.

23

Centers

14

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Refractory Differentiated Thyroid Gland Carcinoma(23)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
73.7
2
NCI Comprehensive
Active Research Program
61.0
3
NCI Comprehensive
Active Research Program
61.0
4
NCI Comprehensive
Active Research Program
61.0
561.0
6
NCI Comprehensive
Active Research Program
61.0
7
NCI Comprehensive
Active Research Program
61.0
8
NCI Comprehensive
Active Research Program
61.0
9
NCI Comprehensive
Active Research Program
61.0
10
NCI Comprehensive
Active Research Program
61.0
11
Active Research Program
61.0
12
Active Research Program
61.0
13
Active Research Program
61.0
14
NCI Comprehensive
39.5
15
NCI Comprehensive
39.5
16
NCI Comprehensive
39.5
17
NCI Comprehensive
39.5
1839.5
19
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
39.5
20
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
39.5
21
NCI Comprehensive
39.5
2239.5
2339.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →